Daniel Liu, PhD, has served for more than two decades in global clinical research departments, in both management and operations, for such multinational drug companies as Novartis, Pfizer, Sanofi, Schering-Plough, Johnson & Johnson, and Medidata. Dr. Liu has served as Core Expert of the NMPA CDE clinical data standardization Committee, and as Vice Chairman of the China Clinical Trial Data Management Group, an advisory member of DIA China committee, and a part-time professor of the NMPA Institute of Exceutive Development, a part-time professor of China Pharmaceutical University. He has taught more than 60 clinical research courses at home and abroad. He earned his PhD from the University of Illinois School of Pharmacy.

Professor Hulihan is Principal with ew hulihan and associates, inc. For over 35+ years, Hulihan has been active in the DIA, in Medicine, as well as providing regulatory consulting, auditing, and training services to the global pharmaceutical community and regulatory authority personnel worldwide.